Methylprednisolone-induced liver injury: A diagnostic challenge

Israel Medical Association Journal

Volumn 16, Issue 3, 2014, Pages 180-181

  Melamud, Bernardo ^a   Lurie, Yoav ^a   Goldin, Eran ^a   Levi, Izhar ^b   Esayag, Yaacov ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Drug induced liver injury (DILI); Druginduced liver injury; Graves' ophthalmopathy; Hepatotoxicity; Methylprednisolone; Naranjo scale

Indexed keywords

ATORVASTATIN; BILIRUBIN; CIPROFIBRATE; METHYLPREDNISOLONE;

ADULT; ARTHRALGIA; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOCRINE OPHTHALMOPATHY; FOLLOW UP; HUMAN; HYPOTHYROIDISM; JAUNDICE; LIVER TOXICITY; MALE; MIDDLE AGED; NOTE; WEAKNESS;

ADMINISTRATION, INTRAVENOUS; DRUG-INDUCED LIVER INJURY; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG;

EID: 84897944085     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Bell, LN Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis 2009; 29: 337-47.
2. Topal F, Ozaslan E, Akbulut S, Kucukazman M, Yuksel O, Altiparmak E Methylprednisoloneinduced toxic hepatitis. Ann Pharmacother 2006, 40: 1868-71.
3. Rivero FM, Riesco JM, Moreira VF, et al. Recurrent acute liver toxicity from intravenous methylprednisolone. Rev Esp Enferm Dig 2008; 100 (11): 720-3.
4. Hofstee H, Nannayakkara P, Stehouwer C. Acute hepatitis related to prednisolone. Eur J Intern Med 2005; 16: 209-10.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.